| Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors (NCT00003288) | National Cancer Institute (NCI) | 1998-08-01 |
| Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer (NCT00003451) | National Cancer Institute (NCI) | 1998-08-01 |
| Irofulven in Treating Children With Recurrent or Refractory Solid Tumors (NCT00003370) | National Cancer Institute (NCI) | 1998-08-01 |
| Studies of Human Herpesvirus 8 and Kaposi's Sarcoma in Sicily (NCT00339937) | National Cancer Institute (NCI) | 1998-07-30 |
| Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection (NCT00001701) | National Cancer Institute (NCI) | 1998-07-29 |
| Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis Infection (NCT00001702) | National Cancer Institute (NCI) | 1998-07-29 |
| Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence (NCT00001705) | National Cancer Institute (NCI) | 1998-07-01 |
| Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic (NCT00003440) | National Cancer Institute (NCI) | 1998-07-01 |
| Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps (NCT00118365) | National Cancer Institute (NCI) | 1998-07-01 |
| Interleukin-12 in Treating Patients With Advanced Cancer (NCT00003330) | National Cancer Institute (NCI) | 1998-07-01 |
| Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma (NCT00026910) | National Cancer Institute (NCI) | 1998-07-01 |
| Genetic Susceptibility to Oncogenic Viruses (NCT00341484) | National Cancer Institute (NCI) | 1998-06-01 |
| Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR (NCT00001698) | National Cancer Institute (NCI) | 1998-06-01 |
| A Pilot Study of Adherence to Oral Medication and Health Beliefs of Adolescents With HIV and Their Mothers (NCT00001699) | National Cancer Institute (NCI) | 1998-06-01 |
| Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis (NCT00003368) | National Cancer Institute (NCI) | 1998-06-01 |
| Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation Therapy (NCT00019357) | National Cancer Institute (NCI) | 1998-06-01 |
| Prostate Lung Colorectal and Ovarian (PLCO) Cancer Screening Trial (NCT00339495) | National Cancer Institute (NCI) | 1998-05-01 |
| LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors (NCT00019435) | National Cancer Institute (NCI) | 1998-05-01 |
| Flavopiridol in Treating Patients With Recurrent Prostate Cancer (NCT00003256) | National Cancer Institute (NCI) | 1998-05-01 |
| Bryostatin and Vincristine in B-Cell Malignancies (NCT00003166) | National Cancer Institute (NCI) | 1998-05-01 |
| Gene Therapy in Treating Patients With Advanced Bladder Cancer (NCT00003167) | National Cancer Institute (NCI) | 1998-05-01 |
| Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers (NCT00003249) | National Cancer Institute (NCI) | 1998-05-01 |
| Interdisciplinary Case-Control Study of Non-Hodgkin's Lymphoma (NCT00341952) | National Cancer Institute (NCI) | 1998-04-15 |
| A Pharmacokinetic Study of Genistein, a Tyrosine Kinase Inhibitor (NCT00001696) | National Cancer Institute (NCI) | 1998-04-01 |
| Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (NCT00019461) | National Cancer Institute (NCI) | 1998-04-01 |
| Survey of the Use of Alternative Medical Therapies in Adult Cancer Patients Enrolled in Phase I Clinical Trials (NCT00001695) | National Cancer Institute (NCI) | 1998-04-01 |
| Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases (NCT00001686) | National Cancer Institute (NCI) | 1998-03-19 |
| Continuation of Follow-up of DES-Exposed Cohorts (NCT00340600) | National Cancer Institute (NCI) | 1998-03-18 |
| Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease (NCT00026884) | National Cancer Institute (NCI) | 1998-03-12 |
| Studies of Thyroid Abnormalities in Northeastern Kazakhstan Associated With Nuclear Weapons Testing (NCT00341185) | National Cancer Institute (NCI) | 1998-03-05 |
| Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers (NCT00001693) | National Cancer Institute (NCI) | 1998-03-01 |
| Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's Lymphoma (NCT00003204) | National Cancer Institute (NCI) | 1998-03-01 |
| Fenretinide in Treating Children With Solid Tumors (NCT00003191) | National Cancer Institute (NCI) | 1998-03-01 |
| EF5 in Treating Patients With Solid Tumors (NCT00003282) | National Cancer Institute (NCI) | 1998-03-01 |
| Lobradimil and Carboplatin in Treating Children With Brain Tumors (NCT00019422) | National Cancer Institute (NCI) | 1998-03-01 |
| Environmental and Biological Monitoring Pilot Study for Polycyclic Aromatic Hydrocarbons in Linxian, China (NCT00342472) | National Cancer Institute (NCI) | 1998-02-12 |
| Gene Therapy in Treating Patients With Cancer of The Liver (NCT00003147) | National Cancer Institute (NCI) | 1998-02-01 |
| Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease (NCT00003210) | National Cancer Institute (NCI) | 1998-02-01 |
| flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell Cancer (NCT00019396) | National Cancer Institute (NCI) | 1998-02-01 |
| A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine (NCT00001688) | National Cancer Institute (NCI) | 1998-01-01 |
| A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With Leukemia (NCT00001689) | National Cancer Institute (NCI) | 1998-01-01 |
| Vaccine Therapy in Treating Patients With Recurrent or Refractory Metastatic Melanoma (NCT00019383) | National Cancer Institute (NCI) | 1998-01-01 |
| Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia (NCT00003190) | National Cancer Institute (NCI) | 1998-01-01 |
| Trafficking of Indium-III-Labeled Cultured Immune Cells in Patients Undergoing Immunotherapy for Advanced Cancer (NCT00026897) | National Cancer Institute (NCI) | 1997-12-01 |
| Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase (NCT00001685) | National Cancer Institute (NCI) | 1997-11-01 |
| A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus (NCT00001680) | National Cancer Institute (NCI) | 1997-10-01 |
| Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors (NCT00019331) | National Cancer Institute (NCI) | 1997-10-01 |
| Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer (NCT00004032) | National Cancer Institute (NCI) | 1997-10-01 |
| Penclomedine in Treating Patients With Solid Tumors or Lymphoma (NCT00002946) | National Cancer Institute (NCI) | 1997-10-01 |
| A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer (NCT00001683) | National Cancer Institute (NCI) | 1997-10-01 |
| A Pilot Study of the Patterns of Cellular Gene Expression in HIV-1 Patients Following Clinical Events Which Increase Plasma Virus Concentrations (NCT00001681) | National Cancer Institute (NCI) | 1997-10-01 |
| Cancer Risk in X-Ray Technologists: Second Survey (NCT00410475) | National Cancer Institute (NCI) | 1997-09-17 |
| Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma (NCT00003039) | National Cancer Institute (NCI) | 1997-09-01 |
| A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver (NCT00001587) | National Cancer Institute (NCI) | 1997-09-01 |
| Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis (NCT00001586) | National Cancer Institute (NCI) | 1997-09-01 |
| Depsipeptide in Treating Patients With Solid Tumors (NCT00019318) | National Cancer Institute (NCI) | 1997-08-01 |
| Flavopiridol in Treating Patients With Refractory Cancer (NCT00019344) | National Cancer Institute (NCI) | 1997-08-01 |
| Determination of HIV-1 Production by the Prostate (NCT00001584) | National Cancer Institute (NCI) | 1997-07-01 |
| A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver (NCT00001576) | National Cancer Institute (NCI) | 1997-07-01 |
| Clinical Evaluation of a Laser Heated, Fiberoptic-Coupled Radiation Dose Verification System (NCT00026871) | National Cancer Institute (NCI) | 1997-07-01 |
| Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer (NCT00001582) | National Cancer Institute (NCI) | 1997-06-07 |
| 506U78 in Treating Patients With Refractory Hematologic Cancer (NCT00002970) | National Cancer Institute (NCI) | 1997-06-01 |
| A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors (NCT00001579) | National Cancer Institute (NCI) | 1997-06-01 |
| Tissue Acquisition for Molecular Diagnostics (NCT00001580) | National Cancer Institute (NCI) | 1997-06-01 |
| Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity (NCT00001577) | National Cancer Institute (NCI) | 1997-06-01 |
| A Population-Based Case-Control Study of Biliary Tract Cancers in Shanghai, China (NCT00339560) | National Cancer Institute (NCI) | 1997-05-16 |
| Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer (NCT00002796) | National Cancer Institute (NCI) | 1997-05-01 |
| A Prospective Cohort Study of Occupational Exposures and Cancer Risk Among Women (NCT00342004) | National Cancer Institute (NCI) | 1997-05-01 |
| Edrecolomab in Treating Patients With Stage II Colon Cancer (NCT00002968) | National Cancer Institute (NCI) | 1997-05-01 |
| Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma (NCT00019214) | National Cancer Institute (NCI) | 1997-04-01 |
| Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia (NCT00001575) | National Cancer Institute (NCI) | 1997-04-01 |
| A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients With Primary and Metastatic Brain Tumors (NCT00001574) | National Cancer Institute (NCI) | 1997-03-14 |
| A Phase I Study of SU101 in Pediatric Patients With Refractory Malignancy (NCT00001573) | National Cancer Institute (NCI) | 1997-03-01 |
| A Pilot Study of Non-Hodgkin's Lymphoma: Chemotherapy and Blood Levels of Organochlorines (NCT00001571) | National Cancer Institute (NCI) | 1997-02-01 |
| Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy & Positron Emission Tomography in the Localization of Recurrent Colorectal Carcinoma in Patients With Rising Serum CEA Levels in the Absence of Imageable Disease by Conventional Modalities (NCT00001568) | National Cancer Institute (NCI) | 1997-02-01 |
| Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia (NCT00002925) | National Cancer Institute (NCI) | 1997-02-01 |
| A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer (NCT00001570) | National Cancer Institute (NCI) | 1997-02-01 |
| Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer (NCT00019136) | National Cancer Institute (NCI) | 1997-02-01 |
| Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma (NCT00002909) | National Cancer Institute (NCI) | 1997-02-01 |
| Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype (NCT00001572) | National Cancer Institute (NCI) | 1997-01-30 |
| EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma (NCT00001563) | National Cancer Institute (NCI) | 1997-01-08 |
| Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia (NCT00002912) | National Cancer Institute (NCI) | 1997-01-01 |
| Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis (NCT00001569) | National Cancer Institute (NCI) | 1997-01-01 |
| Docetaxel in Treating Children With Recurrent Solid Tumors (NCT00002825) | National Cancer Institute (NCI) | 1997-01-01 |
| A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia (NCT00001567) | National Cancer Institute (NCI) | 1997-01-01 |
| Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma (NCT00019188) | National Cancer Institute (NCI) | 1997-01-01 |
| Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers (NCT00001560) | National Cancer Institute (NCI) | 1996-12-24 |
| A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas (NCT00001564) | National Cancer Institute (NCI) | 1996-12-23 |
| A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas (NCT00001566) | National Cancer Institute (NCI) | 1996-12-01 |
| Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer (NCT00004029) | National Cancer Institute (NCI) | 1996-12-01 |
| Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy (NCT00001565) | National Cancer Institute (NCI) | 1996-12-01 |
| Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer (NCT00002913) | National Cancer Institute (NCI) | 1996-12-01 |
| Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection (NCT00019240) | National Cancer Institute (NCI) | 1996-11-01 |
| Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation (NCT00001561) | National Cancer Institute (NCI) | 1996-11-01 |
| Monoclonal Antibody Therapy in Treating Patients With Leukemia (NCT00019227) | National Cancer Institute (NCI) | 1996-10-01 |
| Perillyl Alcohol in Treating Patients With Refractory Cancer (NCT00002862) | National Cancer Institute (NCI) | 1996-10-01 |
| Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer (NCT00002852) | National Cancer Institute (NCI) | 1996-10-01 |
| Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease (NCT00001503) | National Cancer Institute (NCI) | 1996-09-19 |
| Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines (NCT00001512) | National Cancer Institute (NCI) | 1996-09-09 |
| Carmustine in Treating Patients With Recurrent Malignant Glioma (NCT00004028) | National Cancer Institute (NCI) | 1996-09-01 |